Vaxcyte Inc. (PCVX)
NASDAQ: PCVX
· Real-Time Price · USD
32.66
1.23 (3.91%)
At close: Aug 15, 2025, 3:59 PM
32.70
0.12%
After-hours: Aug 15, 2025, 04:54 PM EDT
Vaxcyte Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 306.74M | 346.85M | 387.88M | 1.05B | 518.67M | 611.51M | 397.45M | 545.13M | 531.03M | 949.85M | 834.66M | 366.2M | 238.17M | 201.74M | 68.98M | 112.04M | 151M | 198.94M |
Short-Term Investments | 1.35B | 1.32B | 1.36B | 1.13B | 934.03M | 875.01M | 682.78M | 720.55M | 756.03M | 441.59M | 96.72M | 83.83M | 116.33M | 132.9M | 176.99M | 166.53M | 141.12M | 122.18M |
Long-Term Investments | 1.17B | 1.28B | 1.39B | 1.09B | 400.35M | 413.25M | 163.78M | 168.56M | 153.73M | 127.81M | 26.55M | 3.98M | 6.86M | 17.7M | 27.12M | 39.73M | 48.84M | 49.75M |
Other Long-Term Assets | 95.26M | 77.59M | 25.18M | 3.37M | 52.69M | 3.67M | 37.56M | 4.29M | 4.35M | 4.81M | 5.43M | 5.5M | 6.3M | 6.54M | 4.96M | 4.45M | 1.38M | 1.86M |
Receivables | 100K | n/a | 20.66M | 17.87M | 17.88M | 100K | n/a | 1.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | -9.52M | 12.45M | n/a | 23.13M | -2.4M | -129.12M | -1M | -4.68M | -700K | -100K | -1.2M | -5.7M | -400K | n/a |
Other Current Assets | 54.25M | 44.83M | 20.11M | 4.94M | 1.72M | 22.68M | 15.73M | 14.41M | 23.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.6M |
Total Current Assets | 1.72B | 1.72B | 1.79B | 2.21B | 1.48B | 1.52B | 1.1B | 1.3B | 1.31B | 840.67M | 942.55M | 369.76M | 363.73M | 342.22M | 256.35M | 302.95M | 301.53M | 324.71M |
Property-Plant & Equipment | 327.92M | 304.91M | 332.62M | 249.93M | 152.75M | 157.31M | 110.62M | 27.76M | 34.43M | 34.86M | 31.65M | 32.83M | 34.73M | 36.26M | 35.91M | 6.93M | 6.31M | 6.02M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 1.59B | 1.66B | 1.72B | 1.35B | 605.79M | 574.23M | 311.96M | 200.62M | 192.5M | 167.49M | 63.62M | 42.31M | 47.89M | 60.49M | 67.99M | 51.12M | 56.52M | 57.64M |
Total Assets | 3.31B | 3.38B | 3.51B | 3.56B | 2.09B | 2.09B | 1.41B | 1.5B | 1.5B | 1.01B | 1.01B | 412.06M | 411.62M | 402.72M | 324.34M | 354.07M | 358.05M | 382.35M |
Account Payables | 31.41M | 20.51M | 48.45M | 18.22M | 10.47M | 21.72M | 14.59M | 15.7M | 16.27M | 11.62M | 9.79M | 5.49M | 7.04M | 4.8M | 6.76M | 25.71M | 23.7M | 31.86M |
Deferred Revenue | n/a | n/a | n/a | n/a | -65.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 6.3M | n/a | n/a | 9.64M | 7.29M | n/a | 7.11M | 6.03M | 5.99M | n/a | n/a | 6.43M | 6.64M | 6.58M | n/a | 613K | 710K | 833K |
Other Current Liabilities | 105.94M | 5.99M | 20.55M | 83.69M | 51.33M | n/a | 105.47M | 50.87M | 27.56M | n/a | n/a | 17.52M | 8.08M | 8.02M | n/a | 18.45M | 14.18M | 20.48M |
Total Current Liabilities | 154.49M | 97M | 140.18M | 123.79M | 82.85M | 87.1M | 145.34M | 85.56M | 60.22M | 52.75M | 40.52M | 39.31M | 30.47M | 27.25M | 28.72M | 47.46M | 40.7M | 55.02M |
Long-Term Debt | 79.54M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | 100K | n/a | n/a | n/a | n/a | 2K | 5K | 7K | 9K | 89K | 92K | 93K | 96K | 98K | 100K | 103K |
Total Long-Term Liabilities | 79.54M | 81.08M | 65.32M | 18.32M | 18.29M | 20.22M | 22.11M | 7.78M | 9.23M | 10.64M | 12.04M | 13.45M | 14.65M | 15.93M | 11.6M | 651K | 325K | 398K |
Total Liabilities | 234.03M | 178.08M | 205.5M | 142.11M | 101.14M | 107.32M | 167.45M | 93.34M | 69.44M | 63.39M | 52.56M | 52.75M | 45.12M | 43.17M | 40.32M | 48.11M | 41.03M | 55.41M |
Total Debt | 85.84M | 87.21M | 71.11M | 27.96M | 25.58M | 27.42M | 29.22M | 13.81M | 15.21M | 16.59M | 17.94M | 19.78M | 21.2M | 22.41M | 16.78M | 1.17M | 935K | 1.13M |
Common Stock | 133K | 132K | 128K | 127K | 114K | 112K | 98K | 98K | 97K | 84K | 82K | 64K | 62K | 59K | 56K | 56K | 55K | 54K |
Retained Earnings | -1.7B | -1.53B | -1.39B | -1.25B | -1.15B | -1.02B | -924.39M | -743.59M | -650.93M | -582.59M | -522.13M | -444.08M | -386.16M | -337.63M | -298.64M | -270.08M | -243.46M | -219.78M |
Comprehensive Income | -1.89M | -322K | -3.87M | 139K | 1.81M | 2.89M | 179K | -2.29M | -2.52M | 47K | -361K | -657K | -904K | -833K | -241K | -12K | -8K | -47K |
Shareholders Equity | 3.07B | 3.2B | 3.31B | 3.42B | 1.99B | 1.98B | 1.24B | 1.4B | 1.43B | 944.77M | 953.61M | 359.31M | 366.5M | 359.54M | 284.02M | 305.96M | 317.02M | 326.94M |
Total Investments | 2.52B | 2.6B | 2.75B | 2.22B | 1.33B | 1.29B | 846.55M | 889.11M | 909.76M | 569.4M | 123.27M | 87.8M | 123.19M | 150.6M | 204.1M | 206.27M | 189.96M | 171.93M |